Of Note

Proteins and peptides have unique characteristics which can help with the diagnosis, prognosis, and therapeutic prediction of diseases. The study of these indicators, called proteomics, hinges on accuracy, which is why a lab in South Carolina is working to make the process of identification more precise using automated technology. And if successful, the work done in this lab could help to prevent neurological diseases like Alzheimer’s and Parkinson’s. A leading biotech company, Integrated Micro-Chromatography Systems (IMCS Inc.) has already discovered three product lines of unique enzymes that help indicate neurological illnesses and are used for drug testing. Co-founder and Chief Scientific Officer, Andrew Lee, Ph.D., joins us to breakdown the powerful capabilities of the enzyme his lab is working to develop and what that means for the future of medical science. Andrew unpacks the path to discovery, the importance of patenting your ideas, and why IMCS is determined to make the decoy sugars better, faster, an